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Abstract. 
 
The characteristic shapes and positions of 
each individual body muscle are established during the 
process of muscle morphogenesis in response to pat-
terning information from the surrounding mesen-
chyme. Throughout muscle morphogenesis, primary 
myotubes are arranged in small parallel bundles, each 
myotube spanning the forming muscles from end to 
end. This unique arrangement potentially assigns a cru-
cial role to primary myotube end regions for muscle 
morphogenesis.
We have cloned muscle ankyrin repeat protein 
(MARP) as a gene induced in adult rat skeletal muscle 
by denervation. MARP is the rodent homologue of hu-
man C-193 (Chu, W., D.K. Burns, R.A. Swerick, and 
 
D.H. Presky. 1995. 
 
J. Biol. Chem.
 
 270:10236–10245) 
and is identical to rat cardiac ankyrin repeat protein. 
(Zou, Y., S. Evans, J. Chen, H.-C. Kuo, R.P. Harvey, 
and K.R. Chien. 1997. 
 
Development.
 
 124:793–804). In 
denervated muscle fibers, MARP transcript accumu-
lated in a unique perisynaptic pattern. MARP was also 
expressed in large blood vessels and in cardiac muscle, 
where it was further induced by cardiac hypertrophy. 
During embryonic development, MARP was expressed 
in forming skeletal muscle. In situ hybridization analy-
sis in mouse embryos revealed that MARP transcript 
exclusively accumulates at the end regions of primary 
myotubes during muscle morphogenesis. This closely 
coincided with the expression of thrombospondin-4 in 
adjacent prospective tendon mesenchyme, suggesting 
that these two compartments may constitute a func-
tional unit involved in muscle morphogenesis. Trans-
fection experiments established that MARP protein ac-
cumulates in the nucleus and that the levels of both 
MARP mRNA and protein are controlled by rapid 
degradation mechanisms characteristic of regulatory 
early response genes. The results establish the existence 
of novel regulatory muscle fiber subcompartments as-
sociated with muscle morphogenesis and denervation 
and suggest that MARP may be a crucial nuclear cofac-
tor in local signaling pathways from prospective tendon 
mesenchyme to forming muscle and from activated 
muscle interstitial cells to denervated muscle fibers.
I
 
n 
 
their physiological context in vivo, cells must inte-
grate multiple signals from their environment to fulfill
their specific roles within the organism. This crucial
role of integration is particularly evident during develop-
ment, when cells display coordinate migration, differentia-
tion, and morphogenesis in response to a variety of spe-
cific long-range and local signals. The formation of the
skeletal musculature is an attractive model system in
which to study how patterns of gene expression lead to the
formation of a tissue. Due to major breakthroughs such as
the establishment of differentiating myogenic cell lines, and
the discovery of the converting activity of myogenic deter-
mination factors, the early events in myogenesis, from pre-
determined cells to terminally differentiated myotubes, are
particularly well understood at the cellular level (Bucking-
ham, 1992; Olson and Klein, 1994). In contrast, we know
very little about the mechanisms that control muscle for-
mation within the context of the developing organism. For
example, the morphogenetic events that orchestrate the
formation of the definitive muscle pattern are poorly un-
derstood. These include specific successive splitting of pri-
mordial muscle masses to generate all the different muscles,
directed expansion of the newly formed muscles to gener-
ate their unique shapes, sizes, and positions, and attachment
of the muscles to their specific tendon organs (Lance-Jones,
1979; Schroeter and Tosney, 1991
 
a
 
, 
 
b
 
; Hauschka, 1994). In
the developing mouse limb, these events begin around em-
bryonic day (E)
 
1
 
 12.5, and the definitive muscle pattern is
established by E16 (Lance-Jones, 1979). Throughout mus-
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cle morphogenesis, the muscle pattern is reflected in the
parallel arrangement of primary myotubes that span the
forming muscles from end to end (Fig. 1) (Hilfer et al.,
1973; Hauschka, 1974; Ontell and Kozeka, 1984; Duxson
and Usson, 1989; Sweeney et al., 1989). After completion of
muscle morphogenesis, primary myotubes then serve as
scaffolds for secondary muscle fibers, which are generated
through the proliferation and differentiation of intramus-
cular precursor cells (Ross et al., 1987; Condon et al., 1990;
Ashby et al., 1993).
Classical embryological experiments have established that
myogenic precursor cells are not predetermined with re-
spect to the particular muscles that they will contribute to
(Chevallier et al., 1977). Potential instructive roles by form-
ing nerve or vasculature patterns have been essentially
ruled out, and it is now clear that most morphogenetic in-
formation is derived from the surrounding mesenchyme
(Chevallier et al., 1977; Lanser and Fallon, 1987; Grim,
1991; Ashby et al., 1993). How does patterned mesen-
chyme induce and control muscle morphogenesis? The
fact that the spatial and temporal patterns of muscle split-
ting and shaping are unique for each muscle and do not re-
flect general gradients of limb differentiation (Grim, 1991;
Schroeter and Tosney 1991
 
a
 
,
 
b
 
) argues for specific local
signaling processes. In principle, the end-to-end and paral-
lel arrangement of primary myotubes within the forming
muscles assigns a unique potential role to myotube end re-
gions for muscle morphogenesis (Fig. 1). Accordingly, one
possibility is that mesenchyme-to-muscle signaling may in-
volve local regulation of myotube formation, orientation,
and growth at the interface between myotube end regions
and adjacent mesenchyme. Such local signaling should be
reflected in the expression of corresponding molecular
markers in the mesenchyme and in the responding muscle
cells as well as in the existence of a spatially restricted sub-
compartment at primary myotube end regions.
In a search for genes involved in the regulation of mus-
cle gene expression and the formation of neuromuscular
synapses, we constructed and screened a cDNA library en-
riched in messages induced in adult skeletal muscle by
denervation. As reported elsewhere, two clones coded for
a striated muscle-specific positive regulator of myogenesis:
muscle LIM protein (MLP; Arber et al., 1994) and throm-
bospondin-4 (TSP-4; Arber and Caroni, 1995), whose ex-
pression is induced in denervated muscle interstitial cells. We
report here that a third clone codes for a nuclear protein
with four ankyrin repeats that is expressed in striated mus-
cle and vascular endothelial cells. Due to its predominant
expression in striated muscle we have called it MARP (mus-
cle ankyrin repeat protein). During the course of this work,
isolation of the homologous human protein (C-139; Chu
et al., 1995) and of the identical rat cDNA (cardiac ankyrin
repeat protein [CARP]; Zou et al., 1997) were reported.
MARP mRNA has degradation-promoting motifs charac-
teristic of regulatory factors. Consistent with a possible
role in signaling, MARP protein is rapidly degraded in the
cell, and degradation can be substantially delayed by the
addition of short carboxyl-terminal extentions. The distri-
bution of MARP mRNA in developing mouse skeletal mus-
cle revealed a unique and highly localized pattern associ-
ated with muscle morphogenesis. This was accompanied
by a complementary pattern of TSP-4 expression in adja-
cent mesenchyme. The results establish the existence of
novel muscle subcompartments associated with muscle
morphogenesis and the perisynaptic region of denervated
muscle and suggest that MARP may be a key nuclear co-
factor in novel local signaling pathways to muscle.
 
Materials and Methods
 
Nucleic Acid Reagents
 
A partial clone coding for rat MARP was isolated from a subtracted plas-
mid cDNA library enriched in transcripts induced in adult diaphragm
muscle 7 d after denervation. The construction of the library and the
screening procedure were as described (Arber et al., 1994). Subsequently,
several additional clones, including a 1.7-kb putative full length clone
were isolated through rescreening of the same library. Mouse MARP
cDNA clones were isolated from an adult mouse heart cDNA library, due
to their hybridization to a rat MARP cDNA probe. A genomic clone con-
taining MARP proximal promoter sequences was isolated with mouse
MARP cDNA probes from a mouse (strain 129Sv) genomic library (Strat-
agene GmbH, Heidelberg, Germany). The promoter fragment shown in
Fig. 2 
 
C
 
 drives the expression of a reporter gene in transfected myogenic
cell lines, indicating that it is a functional promoter (data not shown). cDNAs
for Northern blot analysis and in situ hybridization were from the follow-
ing sources: rat MLP (Arber et al., 1994), rat TSP-4 (Arber and Caroni,
1995), rat clone-16 (a cDNA isolated in our screen for denervation-
induced genes; see Aigner et al., 1995), rat MyoD (kind gift from A. Buo-
nanno, National Institutes of Health, Bethesda, MD), mouse tenascin-C
(kind gift from R. Chiquet-Ehrismann, Friedrich Miescher Institute, Basel,
Switzerland), mouse FGF6 (probe corresponding to 434 bp of 3
 
9
 
 untrans-
lated sequences, as in deLapeyriére et al., 1993; kind gift of D. Birnbaum,
U119 Institut National de la Sante et de la Recherche Medicale, Marseille,
Figure 1. Schematic representation of the spatial arrangement of
myogenic cells during muscle formation. Muscle morphogenesis
produces the definitive shape and arrangement of each individual
muscle and precedes the formation of secondary myotubes. From
their first appearance, primary myotubes (shaded rectangles)
span forming muscles in a parallel end-to-end arrangement. Dur-
ing muscle morphogenesis, a substantial part of the muscle mass
contains undifferentiated myoblasts (circles), and primary myo-
tubes are arranged in parallel bundles of three to seven. When
morphogenesis is completed, primary myotube bundles dissoci-
ate, and single primary myotubes serve as scaffolds along which
secondary myotubes (white rectangles) fuse and elongate. Note
that due to the particular arrangement of the primary myotubes,
muscle splitting and shaping may in principle be regulated by
controlling the position and local elongation of primary myotube
end regions. The latter process may involve selective fusion of
myoblasts to primary myotube end regions.
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France), mouse protein kinase A subunits Ri
 
a
 
 and C
 
a
 
 (kind gift of M.C.
Weiss, Institut Pasteur, Paris, France).
 
Nucleic Acid Hybridization
 
RNA isolation and Northern blot analysis with digoxigenin-labeled ribo-
probes (reagents from Boehringer Mannheim Corp., Indianapolis, IN)
were carried out as described in a previous study (Arber et al., 1994). For
Northern blots, equal amounts of total RNA were loaded on a fomalde-
hyde gel, as verified by staining with methylene blue. In situ hybridization
with digoxigenin-labeled cRNA probes was carried out according to a pub-
lished protocol (Schaeren-Wiemers and Gerfin-Moser, 1993). For mouse
embryos, the morning when a vaginal plug was detected was considered as
E0.5. Embryos were fixed in 4% paraformaldehyde in PBS overnight at
4
 
8
 
C. After extensive cryoprotection with 30% sucrose in PBS (4
 
8
 
C), fixed
embryos were mounted in embedding medium and quickly frozen at
 
2
 
40
 
8
 
C in 2-methybutane. 12–14 
 
m
 
m cryosections were pretreated and hy-
bridized overnight at 72
 
8
 
C, as described. The conditions for the proteinase
K (Boehringer Mannheim Corp.) pretreatments of the sections (at room
temperature and in 50 mM Tris, pH 7.5, 5 mM EDTA) were as follows:
E11.5–13.5 embryos: 5 min, 1 
 
m
 
g/ml; E14.5–17.5 embryos: 8 min, 1 
 
m
 
g/ml;
P1 tissue: 5 min, 5 
 
m
 
g/ml; adult muscle: 6 min, 20 
 
m
 
g/ml. Complete sets of
consecutive sections for the comparative analysis of expression patterns
were processed in parallel, and the experiments were carried out with sev-
eral independent groups of embryos, with comparable results. In control
experiments, the specificity of the in situ hybridization signals was verified
by the complete absence of any detectable signal with corresponding
sense probes. Visualization of histological features on adjacent sections
with hematoxylin–eosin stains or with an acetylcholine esterase reaction
was according to standard procedures.
 
Transfection and Coculture Experiments
 
All cell lines (mouse 3T3 fibroblasts; mouse C2C12 myoblasts; rat L6 my-
oblasts; rat 10T1/2 fibroblasts; monkey kidney epithelial cells COS-1)
were from American Type Cell Culture Collection (Rockville, MD). Cells
were cultured, transfected with the lipofectamine reagent (GIBCO BRL,
Gaithersburg, MD), and differentiated as described (Arber et al., 1994).
When indicated, cultures were treated for 6 to 8 h with 10–50 
 
m
 
g/ml cyclo-
heximide (Fluka, Buchs, Switzerland). For transfections, a CMV pro-
moter-based eukaryotic expression vector (pcDNA3; Invitrogen, San Di-
ego, CA) was used. To obtain a MARP construct devoid of 3
 
9
 
 ATTTA
motifs, cDNA sequences downstream of nucleotide 999 (i.e., 37 bp 3
 
9
 
 from
the MARP stop codon) were deleted, and the deletion construct was sub-
cloned in pcDNA3. Epitope tags were added to MARP cDNA using the
PCR, with appropriate primers. The corresponding MARP constructs had
the following amino acid sequences: MEQKLISEEDLN-MM . . . (Myc-
MARP); ..ATFAAAPMEQKLISEEDLN (MARP-Myc); MEQKLI-
SEEDLNI-MMV. . . .ATFAAAPGLVVMNIT (Myc-MARP-GLVVM-
NIT). The rabbit antibody against the synthetic carboxyl-terminal peptide
VLRVEELVTGKKC of MARP was produced by coupling the peptide to
keyhole lympet hemocyanin (Sigma Chemical Co., St. Louis, MO) via a
carboxyl-terminal Cys. Further antibodies were from the following sources:
rabbit antiserum to carboxyl-terminal peptide GLVVMNIT (kind gift of
R. Chiquet-Ehrismann, Friedrich Miescher Institute), monoclonal anti-
body to Myc epitope (kind gift of A. Matus, Friedrich Miescher Institute),
monoclonal antibody to sarcomeric 
 
a
 
-actinin (Sigma Chemical Co.). For
immunoblots, tissues or cells were homogenized in SDS-PAGE sample
buffer, homogenates were boiled, and solubilized proteins were fraction-
ated. For immunocytochemistry, cells (usually 24 h after transfection) were
fixed for 10 min at room temperature with 4% paraformaldehyde in PBS
and then permeabilized for 7 min at room temperature with 0.2% Triton
X-100 in PBS. Antibody incubations were carried out in PBS with 5%
BSA, and all washes were in PBS. Double-labeling immunocytochemistry
was carried out with biotinylated secondary antibodies, followed by lucifer
yellow–conjugated streptavidin for the first channel and rhodamine-cou-
pled second antibodies for the second epifluorescence channel. All sec-
ondary antibodies were from Molecular Probes Inc. (Eugene, OR).
4–5 h before the addition of muscle-derived cells, COS or COS-TSP-4
cells (Arber and Caroni, 1997) were plated at densities of 40,000–80,000
cells on laminin-coated 35-mm culture dishes in the presence of DME
with 10% horse serum and 5% chick embryo extract. Muscle-derived cells
consisted mainly of myoblasts and fibroblasts and were obtained and cul-
tured according to standard procedures. Briefly, muscle from the hind
limbs of P0-P1 mice was minced, trypsinised for 45 min at 37
 
8
 
C, and tritu-
rated with a pasteur pipette in the presence of DNaseI. Cells were then fil-
tered through a cell strainer (70 
 
m
 
m) and preplated for 1.5 h in DME with
10% horse serum and 5% chick embryo extract. Nonadherent cells were
counted, and 500,000 cells were plated onto the laminin/COS or laminin/
COS-TSP-4 dishes. After 2 d of coculture the medium was changed to
DME with 2% horse serum (differentiation medium), and myotube for-
mation was scored 1 and 2 d later.
 
Results
 
MARP Is an Inducible Gene of Adult Skeletal and 
Heart Muscle
 
We isolated MARP cDNA as a clone that was strongly in-
duced by denervation in adult skeletal muscle (see Arber
et al., 1994, where MARP was designated as clone 4). The
deduced amino acid sequence codes for a protein of 319
amino acids, with four ankyrin repeats. The sequence of
rat MARP is shown in Fig. 2 
 
A.
 
 It is identical to that of rat
CARP (Zou et al., 1997) and 90% homologous to the hu-
man cDNA C-193, which was identified as an immediate
Figure 2. Sequence of rat MARP and of the mouse MARP pro-
moter. Induction of MARP in denervated skeletal muscle. (A)
Deduced amino acid sequence of rat MARP. The bipartite nu-
clear localization sequence is underlined, and the first residues of
the four ankyrin repeats are in bold. (39 UTR) Partial sequences
of rat (R) and human (H) MARP mRNA with the ATTTA deg-
radation sequences (bold). (B) MARP mRNA contents in adult
rat tissues. Northern blot of comparable amounts of total RNA
from heart (H), intestine (I), diaphragm muscle (M), skin (S),
lung (Lu), liver (Li), kidney (Ki), brain (B), placenta (P), and
gastrocnemius muscle before (D0) and 0.7, 2, 3, and 7 d after de-
nervation, or 3 and 8 d after Botulinum toxin-A–induced paralysis
(P). Note strong induction by denervation or paralysis of skeletal
muscle. (C) Nucleotide sequence of the proximal promoter of
mouse MARP. Muscle E-box sequences are in bold; muscle
CCAC boxes are underlined.
 o
n
 January 4, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published December 1, 1997
 The Journal of Cell Biology, Volume 139, 1997 1234
 
early gene of vascular endothelial cells (Chu et al., 1995).
Shared elements include a bipartite nuclear localization
motif (residues 71–80 and 94–103), a PEST-like sequence
characteristic of rapidly degraded proteins (residues 108–
126; Rechsteiner and Rogers, 1996), and the four ankyrin
repeats (Blank et al., 1992; residues 152–184, 185–217, 218–
250, and 251–283) that are flanked by a carboxyl-terminal
extension of 36 residues. In addition, the MARP (rat, mouse)
and C-193 (human) transcripts contain multiple ATTTA
degradation motifs (Shaw and Kamen, 1986) in their 3
 
9
 
 un-
translated sequences (Fig. 2 
 
A
 
). Based on the high degree
of sequence homology and the conserved regulatory prop-
erties of the transcripts and proteins (see below), we tenta-
tively conclude that MARP is the rodent homologue of
C-193. As shown in Fig. 2 
 
B
 
, adult rat heart contained high
levels of MARP mRNA, whereas very low levels were de-
tected in lung and placenta, and either no or extremely low
signals were detected in intestine, skeletal muscle, skin,
liver, kidney, and brain. Denervation led to massive induc-
tion of MARP mRNA in skeletal muscle (Fig. 2 
 
B
 
). Com-
parison with other denervation-sensitive transcripts showed
that MARP induction was particularly rapid (significantly
faster than MLP and clone-16 and at least as fast as myo-
genin; not shown). Finally, Fig. 2 
 
C
 
 shows the sequence of
the proximal promoter of mouse MARP. Consistent with
the expression of MARP in skeletal and heart muscle, this
sequence includes five muscle E-boxes and three CCAC-
boxes that regulate transcription in skeletal and cardiac
muscle cells (Fig. 2 
 
C
 
; Buckingham, 1992; Grayson et al.,
1995).
Fig. 3 
 
A
 
 shows that no MARP transcript was detectable
in adult medial gastrocnemius muscle, where strong ex-
pression in the vicinity of acetylcholine esterase–positive
neuromuscular synapses was induced by denervation. At
closer inspection, the MARP signal frequently highlighted
striations and accumulated in a longitudinal pattern along
the inner face of muscle fibers, indicating that it was local-
ized inside skeletal muscle fibers (Fig. 3 
 
B
 
). This dramatic
accumulation pattern in denervated muscle had features
unique to MARP. Thus: (
 
a
 
) MyoD and MLP transcripts
accumulated throughout denervated muscle fibers, and
the signal for clone-16 mRNA only showed partial synap-
tic enrichment (data not shown); (
 
b
 
) although the 
 
a
 
 sub-
unit of the acetylcholine receptor displays some synaptic
enrichment, it is largely due to its synaptic expression in
innervated muscle, and synaptic accumulation is in fact
reduced in denervated muscle (Fontaine and Changeux,
1989; Witzemann et al., 1991); (
 
c
 
) while typical synapse-
associated transcripts such as the 
 
a
 
 subunit of the acetyl-
choline receptor or the regulatory subunit RI
 
a
 
 of protein
kinase A display local accumulation restricted to the sub-
synaptic region (i.e., coincident with acetylcholine esterase
reaction product; data not shown; see Witzemann et al.,
1991; Imaizumi-Scherrer et al., 1996), MARP transcript
accumulated in a much broader perisynaptic pattern, sug-
gesting local regulation by signals in the vicinity of dener-
vated synapses. Unlike these muscle fiber transcripts, and
as reported previously, TSP-4 mRNA accumulated in mus-
cle interstitial cells (Fig. 3 
 
B
 
; see also Arber and Caroni,
1995). In innervated muscle it was restricted to epimysium,
whereas denervation induced expression in the endomy-
sium (Arber and Caroni, 1995). Interestingly, induction
was distinctly more pronounced in perisynaptic regions,
providing a first example of spatial correlation between the
accumulation of MARP mRNA in muscle fibers and that
of TSP-4 in adjacent cells (see below). The dramatic peri-
synaptic accumulation of MARP transcript in denervated
muscle is highly unusual. It suggests that this transcript is
subject to local regulatory mechanisms and that even several
days after removal of the motor nerve the perisynaptic region
of muscle is under the influence of distinct local signals.
Figure 3. Local patterns of MARP transcript induction in adult
denervated muscle and hypertrophic heart. (A) Perisynaptic ac-
cumulation of MARP transcript in denervated muscle. Gastroc-
nemius muscle of adult mice was collected 7 d after resection of
the sciatic nerve. Note prominent MARP in situ hybridization
signal at a broad region near to acetylcholine esterase reaction
product (adjacent section on the right). As expected from the ab-
sence of the corresponding mRNA on Northern blots, no MARP
signal was detected in control muscle (right). (B) High-magnifica-
tion photographs of MARP (left) and TSP-4 (right) transcript lo-
calization in the perisynaptic region of 7-d denervated gastrocne-
mius muscle. Note MARP signal along the inner face of striated
muscle fibers. Distribution of the TSP-4 transcript, which accu-
mulates in a muscle interstitial cell pattern clearly distinct from
that of MARP is shown for comparison. (C) Induction of MARP
transcript in the hypertrophic heart. (Left) In situ hybridization
for MARP mRNA in adult mouse heart. In control heart MARP
mRNA is expressed at high levels in atria and at low levels in
ventricles. In the hearts of MLP-deficient mice (2/2) with di-
lated cardiomyopathy and hypertrophy (Arber et al., 1997),
MARP transcript is strongly upregulated in ventricles. (Right)
Selective upregulation of MARP mRNA in hypertrophic ventri-
cles. The Northern blot was hybridized with a MARP probe and
comparable amounts of total RNA from adult ventricle (H) or
gastrocnemius muscle (Mu) from control or MLP-deficient (2/2)
mice were applied to the gel. Bar: (A) 70 mm, (B, MARP) 8 mm,
(B, TSP-4) 16 mm.
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Fig. 3 
 
C
 
 shows the localization of MARP transcript in a
control and an MLP-deficient mouse heart with dilated
cardiomyopathy and hypertrophy (Arber et al., 1997). In
control hearts, MARP mRNA levels were very high in
atria, whereas ventricles displayed a characteristic inho-
mogeneous distribution. Interestingly, and similar to atrial
natriuretic factor (Chien et al., 1992), cardiac hypertrophy
led to massive induction of MARP message in ventricular
cardiomyocytes, whereas atrial levels were much less af-
fected. Fig. 3 
 
C
 
 also shows that although by Northern blot
MARP was expressed at substantial levels in the heart of
normal adult mice (Fig. 2 
 
B
 
), hypertrophic hearts con-
tained markedly elevated levels of MARP transcript. Un-
like MARP, the denervation-sensitive transcripts MLP
and clone-16 were not elevated in hypertrophic heart
(data not shown). MARP is therefore an inducible gene in
both adult skeletal and heart muscle.
 
MARP Is a Nuclear and Cytosolic Protein Subject to 
Tight Posttranscriptional Regulation
 
To investigate the cellular regulation of MARP mRNA we
analyzed its levels in non- and myogenic cell lines. As shown
in Fig. 4 
 
A
 
, the transcript could be detected in the myo-
genic cell line C2C12, in 10T1/2 fibroblasts, but not in 3T3
fibroblasts. Significantly, when C2C12 cells were trans-
ferred to differentiation medium, MARP transcript levels
were selectively upregulated in myotubes (Fig. 4 
 
B
 
). Myo-
genic cell lines exhibited varying degrees of coupling be-
tween MARP transcript levels and differentiation. Thus,
while one batch of C2C12 cells displayed detectable ex-
pression only upon differentiation (see Arber et al., 1994),
a second C2C12 batch (Fig. 4 
 
A
 
) and L6 cells (data not
shown) already expressed significant levels under nondif-
ferentiating conditions. In 10T1/2 cells, but much less so
in C2C12 cells MARP mRNA levels were elevated in the
presence of the protein synthesis inhibitor cycloheximide
(Fig. 4 
 
A
 
). This is reminiscent of human vascular endothe-
lial cells, where C-193 transcript has early response prop-
erties in small vessel cells and is expressed at much higher
levels in large vessel cells (Chu et al., 1995).
The rat MARP transcript has five closely spaced ATTTA
motifs in its 3
 
9
 
 untranslated sequence (Fig. 2 
 
A
 
). Deletion
of 3
 
9
 
 untranslated sequences, including the ATTTA mo-
tifs, resulted in dramatically higher transcript levels in trans-
fected 3T3 cells, confirming that MARP mRNA carries func-
tional degradation signals (Fig. 4 
 
A
 
). Similar results were
obtained with transfected C2C12 and 10T1/2 cells (data not
shown). To analyze the regulation and subcellular localiza-
tion of MARP we generated an antiserum against the amino-
terminal end of the protein. Surprisingly, in spite of the
substantial corresponding Northern blot signals, MARP
 
Figure 4.
 
MARP has properties of a nuclear early response gene.
(
 
A
 
) Regulation of MARP mRNA contents by myogenic differen-
tiation, cycloheximide, and 3
 
9
 
 untranslated sequences (
 
UTR
 
). The
RNA blots (equivalent amounts of total RNA for each blot) were
hybridized with a rat MARP probe. The experiment on the left
was carried out with a C2C12 subclone exhibiting MARP induc-
tion during differentiation (days). The C2C12 subclone used for
the cycloheximide (
 
CHX
 
) induction experiment already expressed
high levels of MARP in high-serum medium, whereas CHX in-
 
duced MARP transcript in 10T1/2 fibroblasts. (
 
2
 
 
 
and 1) RNA
collected after 6 h without or with CHX. For the experiments on
the right, Swiss 3T3 fibroblasts were transfected with MARP ex-
pression constructs containing (1) or devoid (2) of 39 untrans-
lated region sequences, and RNA was collected 2 d after transfec-
tion. The presence of MARP 39 untranslated region sequences
led to greatly reduced transcript levels. (0) Nontransfected cells.
(B) In differentiating C2C12 cells MARP transcript selectively
accumulates in multinucleated myotubes (arrows). In situ hybrid-
ization of cultures 3 d after switch to differentiation medium.
(Right) MARP sense probe as a negative control. The C2C12
subclone was as in (A) (Left) Note homogeneous pattern of
MARP transcript accumulation in myotubes in vitro. (C) MARP
protein is rapidly degraded in transfected cells, and degradation
can be delayed by the fusion of short peptide sequences to the
carboxyl-terminal end of the protein. COS cells were transfected
with MARP expression constructs, and MARP contents were de-
termined on the immunoblot (anti-MARP antiserum). Equal
amounts of cell homogenate protein were applied for each sam-
ple (see background band at z31 kD). (N 1 C) myc-tag at the
amino terminus and GLVVMNIT-tag at the carboxy terminus;
(N) myc-tag at the amino terminus; (C) myc-tag at the carboxyl
terminus; (2) no epitope tags. For each MARP construct, cells
were incubated with (1) or without (2) CHX during the last 8 h
before homogenization. (D) Nuclear and cytosolic accumulation
of MARP in transfected COS cells. The epitope-tagged con-
structs are defined as described in (C). (Top) Anti-myc labeling
of amino- (left) and carboxyl-terminal–tagged (right) MARP.
Note higher frequency of labeled cells and of cytosolic signal in
the presence of carboxyl-terminal tag sequence. Double-tagged
(N 1 C) MARP was visualized by double labeling for the amino
terminus (n) and carboxyl terminus (c) epitope tag. Note nuclear
accumulation of undegraded MARP. Bar: (B) 15 mm; (D, single
labelings) 9 mm; (D, double labeling) 6 mm.
 o
n
 January 4, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published December 1, 1997
The Journal of Cell Biology, Volume 139, 1997 1236
protein signals on immunoblots from heart homogenates
were very low, and no signals could be detected on immu-
noblots of differentiated L6 and C2C12 cells (data not
shown). A weak signal could be detected on immunoblots
of transfected COS (Fig. 4 C) and C2C12 cells. To exclude
effects due to the instability of MARP transcripts, all
transfection experiments were carried out with 39 untrans-
lated region–deleted constructs (Fig. 4 A), and the pres-
ence of comparable transcript levels was verified on corre-
sponding Northern blots. To determine whether detection
difficulties were due to poor antisera we analyzed immu-
noblots of cells transfected with epitope-tagged MARP
constructs. These experiments led to the surprising finding
that the addition of short amino acid extensions to the car-
boxyl-terminal end of MARP greatly protected this pro-
tein against degradation. The analysis revealed that addition
of any of two different epitope tags to the carboxyl-termi-
nal end of MARP resulted in greatly elevated levels of the
corresponding protein. In contrast, amino-terminal epitope
tags were ineffective (Fig. 4 C; note that all constructs
were detected with antiserum against a sequence from the
amino-terminal end of MARP). The fact that the car-
boxyl-terminal tags also reduced the decline of MARP
contents in the presence of protein synthesis inhibitor (Fig.
4 C) further argues for protection against protein degrada-
tion. The data of Fig. 4 C were obtained with COS cells,
but similar results were obtained in transfected C2C12 cells
(data not shown).
MARP contains a classical nuclear localization sequence,
suggesting that it may be a nuclear protein. Detection with
MARP-specific antiserum revealed accumulation in the nu-
cleus and in the cytosol of transfected cells (Chu et al.,
1995; Zou et al., 1997). About two thirds of the labeled
cells showed an exclusively nuclear pattern, whereas the
rest of the cells also displayed cytosolic signal (Fig. 4 D).
Cytosolic MARP frequently accumulated in clump-like
structures, suggesting aggregation and/or degradation. To
determine whether the entire MARP protein translocates
to the nucleus and whether stabilization against proteolytic
degradation may reveal selective accumulation in a cellu-
lar compartment, we analyzed the subcellular localization
of epitope-tagged MARP constructs. When amino and
carboxyl-terminus-tagged protein was double labeled for
both epitopes, a majority of the labeled cells displayed
comparable distribution of the two epitopes (Fig. 4 D).
These results indicate that a substantial proportion of ap-
parently intact MARP accumulates in the nucleus (Chu et al.,
1995; Zou et al., 1997). It is therefore likely that this highly
regulated early response protein exerts its function in this
compartment. In addition, the experiments revealed that
besides greatly elevating the number of cells with detect-
able MARP signals (z20-fold increase), carboxyl-terminal
tags also led to a substantially higher proportion of cytoso-
lic MARP in the transfected cells (Fig. 4 D). A possible in-
terpretation of these findings is that carboxyl-terminal epi-
tope tags protect MARP from degradation in the cytosol.
The Spatial and Temporal Distribution of MARP 
mRNA in Embryonic Mouse Skeletal Muscle Coincides 
with Muscle Morphogenesis
In mouse embryos before E11.5, MARP mRNA was only
detectable in the heart and in large blood vessels. Both tis-
sues expressed high levels of MARP transcript at all later
stages of embryogenesis. Prominent expression in the de-
veloping and adult heart is consistent with the findings of
Zou et al. (1997), and selective accumulation of MARP
mRNA in large blood vessels is consistent with the consti-
tutive expression of the human homologue of MARP (C-
193) in endothelial cell lines derived from large, but not
small blood vessels (Chu et al., 1995). Based on the tissue
culture results with myogenic cell lines, the absence of
MARP mRNA in myogenic regions of E10.5 embryos was
unexpected, since in these embryos, determined myogenic
cells already express MyoD, which in mouse skeletal mus-
cle cells is the latest of the myogenic determination factors
(Buckingham, 1992). At E11.5, MARP mRNA was detect-
able in the myotome region (Fig. 5 A). Comparison with
the somitic expression patterns of MyoD, and of MLP,
which is only expressed in terminally differentiated skeletal
muscle cells (Arber et al., 1994), revealed the presence of
MARP transcript in a subset of cells within MLP-positive
territories (Fig. 5 A). In contrast, no MARP expression was
detected in E11.5 forelimb, which contained MyoD-positive,
but MLP-negative cells (Fig. 5 A). This coincidence be-
tween MLP- and MARP-positive areas was consistently
observed between E11.5 and 16.5. The observation that
within MLP-expressing areas MARP-positive cells were
consistently less numerous than those expressing MLP
prompted us to analyze these cells in E14.5 embryos, where
myotubes are easier to identify. As shown in Fig. 5 B,
MLP-positive myotubes were arranged in small clusters of
primary myotubes. These clusters were oriented parallel
to each other and spanned the muscle from end to end
(Fig. 5 B; see Fig. 7, left, for E12.5 data and Fig. 1 for a
schematic representation of myotube arrangement during
muscle morphogenesis). In contrast, MyoD-positive cells,
which included myotubes and muscle precursor cells, dis-
played a more homogeneous distribution. Hybridization for
MARP mRNA revealed a striking pattern specifically as-
sociated with the end regions of primary myotube clusters
(Figs. 5 B, 6, and 7). The higher magnification photographs
show that MARP mRNA accumulated inside multinucle-
ated striated muscle fibers (Fig. 6). Systematic analysis re-
vealed that all MLP-positive muscles in these embryos con-
tained MARP-positive muscle fibers.
The expression of MARP in embryonic skeletal muscle
was restricted to early stages of muscle formation. As shown
in Fig. 7, MARP transcript (left) was detectable in all
MLP-positive muscles (right) between E12.5 and 15.5,
with highest signal levels around E14.5. Throughout this
period, MARP mRNA was consistently restricted to mus-
cle end regions. MARP mRNA levels started to decline af-
ter E15.5, and by E17.5 signals were absent from most
muscles (Fig. 7). Therefore, the temporal and spatial pat-
tern of MARP expression coincides with splitting, shaping,
and tendon attachment of developing muscles, i.e., with
muscle morphogenesis.
During Muscle Morphogenesis Expression of TSP-4 in 
Prospective Tendon Mesenchyme Is Adjacent to that of 
MARP-positive Skeletal Muscle Fibers
What signals are responsible for the striking accumulation
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of MARP transcript at the end regions of primary myo-
tubes in forming muscles? Because of the role of mesen-
chyme in muscle morphogenesis, we searched for tran-
scripts expressed in regions adjacent to MARP-positive
muscle. Due to its association with tendon regions (Tucker
et al., 1994) and its upregulation in interstitial cells of de-
nervated muscle (Arber and Caroni, 1995), TSP-4 was one
potential candidate. Before E12.5, TSP-4 mRNA was de-
tected in the developing heart (data not shown). In addi-
tion, like in the chick (Tucker et al., 1995), TSP-4 mRNA
accumulated in chondrogenic regions of the mouse em-
bryo. Close examination of the TSP-4 signal in the vicinity
of developing cartilage revealed a striking complementar-
ity to the localization of MARP mRNA (Fig. 8). The high-
magnification photographs (Fig. 9 B) show that the MARP
and TSP-4 signals precisely apposed each other, and that
TSP-4 expressing tissue was coextensive to muscle tissue.
Exclusion of muscle transcripts from TSP-4–expressing end
regions was also observed for MLP (Fig. 9) and MyoD
mRNA. Comparable relative localizations of MARP and
TSP-4 transcripts were detected from E13.5 to 17.5 (Figs. 8
and 9). As shown in Fig. 9 B, spatial coincidence was not
restricted to regions adjacent to developing bone. The
characteristic arrangement of the TSP-4 signal with re-
spect to forming muscle suggested that it was associated
with prospective tendon mesenchyme. This conclusion was
supported by the fact that TSP-4–expressing tissue also ac-
cumulated tenascin-C transcript (data not shown; Chiquet
and Fambrough, 1984).
In addition to a close spatial correlation, MARP and
TSP-4 transcripts were also correlated temporally: they
appeared together around E12.5, declined after E15.5, and
were nearly undetectable at most muscle end regions at
E17.5 (Fig. 9 A). This was in contrast to tenascin-C mRNA,
whose expression at the forming tendon persisted beyond
the period of muscle morphogenesis (data not shown).
The tongue provided a striking example of the spatial and
temporal correlation of TSP-4 and MARP transcript accu-
mulation. In this muscle-rich organ with no cartilage, mus-
cle groups are linked by tendinous scaffold. Particularly
high levels of TSP-4 and MARP mRNA were detected in
Figure 5. During muscle formation in vivo, appearance of MARP
transcript coincides with terminal differentiation, and the tran-
script selectively accumulates at muscle end regions. In situ hy-
bridization of mouse embryo sections. MyoD is expressed in myo-
genic cells before and after terminal differentiation; MLP is a
marker for terminally differentiated striated muscle cells. The
horizontal lines indicate consecutive sections (14 mm). (A) At
E11.5, MARP mRNA is detectable within MLP-positive myotome
(left), whereas in the forelimb, MyoD-positive myogenic progeni-
tor cells were negative for MLP and MARP transcripts. (B) At
E14.5, MARP transcript accumulated at end regions of MLP- and
MyoD-positive muscles (top; the example is from foot muscles).
A detail from the top panels (arrows) is shown in the middle pan-
els. Note restriction of MARP transcript to edge of the indentation
in the MLP-positive muscle. The bottom panels show an example
of MARP transcript accumulation at the end of a MyoD-positive
muscle (between ribs). In the corresponding higher magnification
photograph on the right, MARP transcript can be detected inside
striated cells, i.e., primary myotubes (arrows point to spared nu-
clei). Bar: (A) 480 mm; (B, top) 240 mm; (B, middle) 30 mm; (B,
bottom, left) 60 mm; (B, bottom, right) 15 mm.
Figure 6. Accumulation of MARP transcript at end regions of
primary myotubes. Two high-magnification examples of MARP
transcript localization at end regions of facial muscles in an E14.5
mouse embryo are shown. (Left) Nonmuscle region (top right) is
marked with an asterisk, and the three arrows delineate the non-
labeled part of a primary myotube bundle (striations) that ex-
tends towards the opposite end of the muscle; MARP signal is re-
stricted to the end regions of the primary myotube bundles.
(Right) In this example the muscle end is at the top left corner;
multinucleated (arrows; nuclei are spared in the in situ hybridiza-
tion labeling) primary myotube bundles are labeled from the
muscle end, and signal intensity decreases towards the lower right
corner of the figure, i.e., towards the opposite end of the muscle.
Bar, 11 mm.
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the developing tongue, where the two transcripts accumu-
lated at complementary locations. Unlike in other muscles,
expression of both transcripts was maintained throughout
late embryogenesis and was still detectable at postnatal
day 1 (not shown). These observations demonstrate that
prospective tendon mesenchyme adajacent to sites of MARP
mRNA accumulation in myotubes can be visualized by the
expression of TSP-4. The close temporal and spatial rela-
tion between the two transcripts and the likely role of muscle
attachment regions in muscle morphogenesis (Kardon, G.
1996. Dev. Biol. 175:393a) suggest that accumulation of
MARP transcript may be a local response of primary myo-
tubes to TSP-4–expressing mesenchyme.
What types of functional responses may be induced at
muscle end regions by prospective tendon mesenchyme?
As mentioned above, one possibility is local induction of
muscle growth, including proliferation and fusion of myo-
blasts to primary myotubes, myogenic differentiation, and
myotube extension. A previous in vitro study demon-
strated that myoblasts adhere to a peptide corresponding
to the cell-binding carboxyl-terminal end of TSP-4 (Adams
and Lawler, 1994). Accordingly, to determine whether
TSP-4 can promote myogenic differentiation we carried
out coculture experiments with primary myoblasts from
newborn mice and TSP-4–expressing COS cells (COS-TSP-
4; Arber and Caroni, 1995). The latter secrete substantial
amounts of TSP-4, which was shown in a previous study to
efficiently promote neurite outgrowth (Arber and Caroni,
1995). COS-TSP-4 or naive COS cells were plated at low
density on laminin-coated culture dishes, and hind limb
muscle-derived cells were added 4–5 h later. After 2 d in
growth-promoting medium the cultures were switched to
differentiation medium, and myotube formation was scored
1 and 2 d later. As shown in Fig. 10, under these experi-
mental conditions, myogenic differentiation and myotube
formation were markedly potentiated in the presence of
the COS-TSP-4 cells. Muscle-derived cells, which were
noticably smaller and thus easily distinguishable from co-
cultured COS cells, could be detected in comparable
amounts in the two types of cultures. However, in the ab-
sence of TSP-4 these cells only expressed low levels of
muscle-specific a actinin and only rarely fused to myo-
tubes (Fig. 10). The finding that TSP-4 can promote myo-
genic differentiation under these in vitro conditions is con-
sistent with the possibility that secretion of this extracellular
matrix protein by prospective tendon mesenchyme cells is
part of a local signaling process to couple muscle forma-
tion to tendon morphogenesis.
Discussion
MARP Is a Nuclear Protein with Regulatory Properties 
of a Specialized Early Response Gene
The tight regulation of MARP at the posttranscriptional
and posttranslational levels is characteristic of a regulatory
early response gene (McMahon and Monroe, 1992) and
Figure 7. Accumulation of MARP transcript at end regions of
skeletal muscle during muscle morphogenesis. In situ hybridiza-
tion of consecutive sections labeled for MARP (left) and MLP
(right) transcript. The sections display different groups of muscles
between E12.5 and 17.5 (E12.5, face; E13.5 and 15.5, hindpaw;
E17.5, front paw). Note consistent restriction of MARP tran-
script to myotube end regions. MARP expression was strongly
downregulated at E17.5. Bar: (E12.5) 180 mm; (E13.5, 15.5, and
17.5) 360 mm.
Figure 8. At muscle end regions, MARP and TSP-4 transcripts
accumulate at adjacent locations. Consecutive sections (chest
muscles, above heart) from an E14.5 embryo were hybridized for
MLP, MARP, and TSP-4 transcript, as indicated. Note similar
distribution and complementarity of MARP and TSP-4 labeling
patterns (two examples are indicated by the arrowheads). In ad-
dition to regions adjacent to muscle ends, TSP-4 transcript also
accumulated in chondrogenic areas (one example indicated by
the asterisk). Bar, 500 mm.
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suggests that MARP may be a control component in sig-
naling to the nucleus (Chu et al., 1995). Thus the rat, mouse,
and human mRNAs contain multiple ATTTA degrada-
tion motifs in their 39 untranslated sequence; these motifs
affect mRNA levels in transfected cells, and MARP mRNA
contents are elevated in cycloheximide-treated cells. The
latter property is a hallmark of early response genes whose
transcripts are subject to rapid degradation involving short-
lived cellular proteins (McMahon and Monroe, 1992). In
addition, possibly due to the presence of a PEST protein
degradation motif (Rechsteiner and Rogers, 1996), MARP
was difficult to detect in homogenates from tissues and cell
lines with substantial MARP mRNA contents. Transfec-
tion of cDNA constructs devoid of ATTTA motifs led to
transient accumulation of MARP protein with half-lives
,30 min. Addition of short carboxyl-terminal peptide ex-
tensions specifically retarded MARP degradation, sug-
gesting the existence of regulatory mechanisms affecting
MARP levels in the cell. Potential phosphorylation sites of
MARP have been noted adjacent to the PEST-like motif
and near the carboxyl-terminal end of the protein (Chu et
al., 1995). Accordingly, and in analogy to the regulated
degradation of other short-lived proteins, MARP stabili-
zation may be regulated by phosphorylation.
Regulation of MARP levels has cell type- and signal-
specific features. Thus a human cell line with properties of
large vessel vascular endothelial cells expresses compara-
tively high levels of MARP mRNA, whereas corresponding
small vessel cells require activation with IL1, lysophospha-
tidic acid, or cycloheximide for detectable MARP expression
(Chu et al., 1995). Regulation of MARP mRNA levels in
vascular endothelial cells may have similar properties in
vivo, since in mouse embryos, corresponding in situ hy-
bridization signals were only detected along subdomains
of large blood vessels (not shown). Similar cell-type spe-
cific regulation was detected in myogenic and fibroblastic
cell lines. In addition, cell type- and signal-specific regula-
tion was detected in developing and adult mouse muscle in
vivo, where MARP expression was restricted to subtypes
and subdomains of striated muscle cells under defined re-
active conditions. The unique temporal and spatial patterns
of MARP transcript accumulation suggest that MARP
levels may control specific signaling pathways to the nu-
cleus. The observation that certain cell lines can contain
unexpectedly high levels of MARP mRNA may reflect the
absence or attenuation of physiological inhibitory mecha-
nisms under tissue culture conditions. Similar consider-
ations probably apply to primary myotubes from newborn
hindlimb myoblasts, which expressed substantial levels of
MARP mRNA, although the corresponding muscle cells in
vivo contained no detectable MARP transcript (not shown).
What cellular processes may be affected by MARP? Al-
though it accumulates in the nucleus, MARP does not ap-
pear to bind DNA with high affinity (Chou et al., 1995). A
recent independent study focusing on the possible role of
CARP/MARP in heart-specific gene expression provided
evidence that this protein is a nuclear cofactor that pro-
motes the expression of certain muscle-specific genes in
cardiomyocytes (Zou et al., 1997). In that study CARP/
MARP was isolated by a two-hybrid approach as a nuclear
cofactor that interacts with the ubiquitous transcription
factor YB-1. Negative regulation of a YB-1–responsive
Figure 9. TSP-4 transcript
accumulates at prospective
tendon mesenchyme regions
adjacent to MARP-positive
primary myotube ends. In
situ hybridization experi-
ments; horizontal lines indi-
cate adjacent sections. (A)
Spatial and temporal correla-
tion of MARP and TSP-4
transcript accumulation.
Trunk muscles, cervical re-
gion. Note TSP-4 signal adja-
cent to MARP (e.g., at mus-
cle indentations). Also note
that at E17.5 both MARP
and TSP-4 signal were down-
regulated. (B) MARP tran-
script accumulates at the
ends of primary myotubes,
adjacent to TSP-4–express-
ing prospective tendon mes-
enchyme. Consecutive sec-
tions from E13.5 (top) and
E15.5 (bottom) intercostal
muscle. Note coextensive ar-
rangement of MARP- and
TSP-4–expressing structures.
H&E, Haematoxilin and
eosin stain. Bar: (A) 1.1 mm,
(B, top) 35 mm, (B, bottom)
140 mm.
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minimal promoter construct suggested that CARP/MARP
may specifically regulate HF-1–dependent pathways for
ventricular muscle gene expression (Zou et al., 1997). Pos-
sibly due to technical reasons, although a weak CARP/
MARP signal was detected in that study on a Northern
blot of adult skeletal muscle, no in situ hybridization signal
was detected in skeletal muscle at any stage of mouse em-
bryogenesis (hence the name CARP; Zou et al., 1997). As-
suming that the findings on YB-1 regulation can be ex-
tended to skeletal muscle genes, then MARP may be a
nuclear cofactor in a signal transduction pathway for local
cell activation in forming and denervated muscle.
Besides a classical bipartite nuclear localization sequence
and the PEST motif mentioned above, MARP has a clus-
ter of four ankyrin repeats near its carboxyl-terminal end.
Clusters containing different numbers of this 30-amino
acid motif have been found in a variety of apparently un-
related proteins, where they are thought to mediate pro-
tein–protein interactions (Blank et al., 1992). The molecu-
lar size of MARP, the arrangement and number of its
ankyrin repeats, and the fact that it is subject to degrada-
tive regulation in the cell are most reminiscent of IkB pro-
teins. These are negative regulators of NF-kB proteins, a
family of transcription factors mediating acute cellular re-
sponses. To explore the possibility that MARP may func-
tion as an IkB we carried out cotransfection experiments
with various NF-kB constructs, assaying for protein stabil-
ity in the presence and absence of phorbol ester and for
transcriptional activation. So far, however, these experi-
ments provided no positive indications (data not shown).
Therefore, while it is tempting to speculate that MARP
may be involved in novel signal transduction pathways
mediating local alterations in gene expression, elucidation
of the actual nature of the processes affected by MARP
will require further experimentation.
Primary Myotube Endcompartments and Adjacent 
Prospective Tendon Mesenchyme May Constitute a 
Functional Unit Involved in Muscle Morphogenesis
A main finding of this study is that the accumulation of
MARP transcript visualizes a novel muscle subcompart-
ment associated with muscle morphogenesis. MARP mRNA
Figure 11. The local accumulation of MARP mRNA visualizes
novel regulatory muscle subcompartments during muscle mor-
phogenesis and in denervated muscle. (A) During muscle mor-
phogenesis, MARP mRNA accumulates at primary myotube end
regions, adjacent to TSP-4–expressing prospective tendon mesen-
chyme. In contrast, MLP transcript accumulates throughout pri-
mary myotubes, and that for MyoD is also detected in myoblasts.
The arrows with question marks indicate the possible direction of
signaling, from surrounding mesenchyme to tendon mesenchyme
to primary myotube end regions. During muscle morphogenesis,
extensive myoblast proliferation, fusion to preexisting primary myo-
tubes, and myotube elongation may be restricted to muscle end
regions under the control of prospective tendon mesenchyme.
(B) In denervated adult skeletal muscle, MARP mRNA accumu-
lates in the perisynaptic region of muscle fibers, in the vicinity of
activated muscle interstitial cells. The arrow with question mark
indicates the possible direction of signaling from activated muscle
interstitial cells to the perisynaptic region of denervated muscle.
Unlike MARP mRNA, transcripts for classical denervation-
induced genes such as MyoD and MLP accumulate throughout
denervated muscle fibers. In addition, subsynaptic muscle nuclei
express distinct genes in innervated and denervated muscle.
Figure 10. Myogenic differentiation in the presence of COS-TSP-4
cells. Cocultures of control (top; COS) or TSP-4–expressing (bot-
tom; COS-TSP-4) COS cells with newborn hind limb muscle-
derived cells. Culture dishes were precoated with laminin, and ex-
perimental details were as described in Materials and Methods.
The phase contrast photographs of living cells were taken 1 (left)
and 2 (right) d after switch to differentiation medium. The photo-
graphs on the right show immunocytochemistry of muscle-spe-
cific a actinin 2 d after induction of differentiation. Note that in
the presence of naive COS cells, muscle-derived cells frequently
formed chains (top, center) of cells that expressed low levels of
sarcomeric a actinin (top, right) but in most cases failed to fuse to
myotubes. In contrast, efficient formation of myotubes that ex-
pressed high levels of sarcomeric a actinin was detected in the
presence of COS-TSP-4 cells (bottom). Bar: (Left and middle;
phase-contrast) 24 mm; (right; immunofluorescence) 12 mm.
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accumulated at the ends of MLP-positive primary myo-
tubes from about E12 to 16. Later in development, MARP
skeletal muscle signal was restricted to the tongue, where
it could still be detected during the first postnatal week. In
addition, denervation rapidly induced skeletal muscle
MARP mRNA in the vicinity of vacated neuromuscular
synapses. Therefore, in developing and adult skeletal mus-
cle, MARP transcript is under tight spatial and temporal
regulation. Due to the unique size and shape of myotubes
and skeletal muscle fibers, this narrow regulation of MARP
mRNA reveals regulatory subcompartments within mus-
cle fibers. The perisynaptic compartment of functionally
denervated skeletal muscle fibers may reflect signaling
from activated muscle interstitial cells (Fig. 11; Connor and
McMahan, 1987; Gatchalian et al., 1989). The unique prop-
erties of primary myotube end regions during muscle mor-
phogenesis have not been detected before, and the possi-
ble implications of these observations are discussed below.
Muscles form from initial masses of terminally differen-
tiated primary myotubes through a series of stereotyped
splitting processes (e.g., Schroeter and Tosney, 1991a, b).
These are followed by directed lateral extension to yield
the final configurations of shapes, attachment sites, and
positions characteristic for each individual muscle. In the
mouse, this process of muscle morphogenesis is completed
by E15–16 and precedes a second wave of myoblast prolif-
eration and formation of secondary myotubes (Lance-
Jones, 1979; Ross et al., 1987). Primary myotubes then
serve as scaffold for muscle growth (Ashby et al., 1993; Jel-
lies, 1990; Hauschka, 1994). From the earliest time when
primary myotubes could be detected, they were found to
span muscles from end to end in small parallel bundles
(Hilfer et al., 1973; Hauschka, 1974; Duxson and Usson,
1989). This configuration potentially assigns unique prop-
erties to end regions of muscle during morphogenesis (Fig.
11). Such unique properties may be crucial to the morpho-
genesis process. Thus, (a) muscle splitting always proceeds
in one defined direction, starting from one muscle end (ei-
ther from the origin or the attachment site, depending on
the particular muscle; Schroeter and Tosney, 1991b), and
(b) instead of involving cell migration, the morphogenesis
of individual muscles appears to involve local orientation
and growth through myoblast fusion at primary myotube
end regions (e.g., Hauschka, 1994). These regions are now
shown to accumulate MARP transcript in primary myo-
tubes and TSP-4 mRNA in adjacent prospective tendon
mesenchyme. The close temporal and spatial correlation
in the expression of these two transcripts during muscle
morphogenesis suggests that these domains at the ends of
forming muscles constitute a functional unit involved in
the process of morphogenesis (Kardon, G. 1996. Dev. Biol.
175:393a). This interpretation is consistent with the obser-
vation that no obvious physical boundaries could be de-
tected between adjacent TSP-4- and MARP-expressing
tissue and that the two transcripts appeared to be ex-
pressed in coextensive tissue (Fig. 9). Due to the fact that
it is the surrounding mesenchyme that provides the infor-
mation for the formation and shaping of individual mus-
cles, it seems likely that TSP-4- and MARP-expressing
muscle end regions respond to local patterning cues during
the shaping process. One possibility is that local signals in-
duce and guide the formation and shaping of TSP-4–express-
ing prospective tendon mesenchyme (Kardon, G. 1996.
Dev. Biol. 175:393a). This in turn would signal to adjacent
muscle, as visualized by the accumulation of MARP tran-
script and locally promote proliferation, fusion, and elon-
gation of primary myoblasts and myotubes (Fig. 11).
Within this context, extracellular matrix TSP-4 could con-
tribute to a local environment promoting myogenesis. In
addition, the muscle end properties of the MARP-express-
ing subdomain of activated primary myotubes may also
lead to feedback signaling from muscle ends to muscle-
associated and surrounding mesenchyme. One such signal
may be mediated by FGF-6. Thus this transcript preferen-
tially accumulates at the ends of forming muscles between
E12 and 16 (deLapeyriére et al., 1993). Although local ac-
cumulation of FGF-6 mRNA was much less pronounced
than that of MARP transcript, a spatial and temporal cor-
relation between the two transcripts could be detected
(data not shown).
In conclusion, this study has revealed the existence of a
novel muscle subcompartment at the ends of primary myo-
tubes and has provided molecular markers for that sub-
compartment and prospective tendon mesenchyme during
muscle morphogenesis. The spatial and temporal relation
between the compartments defined by the expression of
MARP and TSP-4 suggests that they may define a func-
tional unit involved in muscle morphogenesis. These find-
ings should provide a molecular basis to elucidate novel
local signaling pathways leading to the specification and
shaping of defined skeletal muscles. Likewise, the visual-
ization of a perisynaptic subcompartment in denervated
skeletal muscle may provide a starting point to define
novel signaling pathways at denervated neuromuscular
junctions.
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